 Gilead Sciences Inc NASDAQ: GILD ended in the green on Tuesday after a JPMorgan analyst turned bullish on the biopharmaceutical company. Gilead stock should be worth 80 a share Chriss Schott now rates this healthcare name at overweight and sees upside to 80 a share about a 25 increase from here. 